Showing results (101-110 of 316) with videos related to
Sort By:
Pageof 32
Neurogastroenterology and Motility|June 18, 2024
A diet low in fermentable oligo-, di-, monosaccharides and polyols improves abdominal and overall symptoms in persons with all subtypes of irritable bowel syndromeGregory Dean, Samuel W Chey, Prashant Singh, et al.The American Journal of Gastroenterology|August 28, 2020
Increased Risk of COVID-19 Among Users of Proton Pump InhibitorsChristopher V Almario, William D Chey, Brennan M R SpiegelGastroenterology|October 22, 2020
Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel SyndromeWilliam D Chey, Laurie Keefer, Kevin Whelan, et al.American Journal of Psychoanalysis|August 14, 2024
Remembering Jeremy Safran: continuing the conversationAli Shames-Dawson, Adrienne HarrisClinical and Translational Gastroenterology|July 24, 2019
A Low FODMAP Diet May Reduce Symptoms in Patients With Fecal IncontinenceStacy B Menees, Deepa Chandhrasekhar, Ee Lane Liew, et al.The American Journal of Gastroenterology|May 25, 2011
A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipationWilliam D Chey, Michael Camilleri, Lin Chang, et al.The American Journal of Gastroenterology|December 18, 2020
Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)William D Chey, Anthony J Lembo, Yang Yang, et al.The American Journal of Gastroenterology|March 18, 2006
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysisRichard J Saad, Philip Schoenfeld, Hyungjin Myra Kim, et al.The American Journal of Gastroenterology|November 3, 2011
The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysisStacy B Menees, Monthira Maneerattannaporn, Hyungjin Myra Kim, et al.The American Journal of Gastroenterology|March 17, 2022
Optimal Design of Clinical Trials of Dietary Interventions in Disorders of Gut-Brain InteractionHeidi M Staudacher, Chu Kion Yao, William D Chey, et al.Pageof 32